Full-Time
Motion Designer
Posted on 3/25/2026
Brainlab
1,001-5,000 employees
Medical software and hardware for surgeries
No salary listed
Munich, Germany
Hybrid
 Art, Graphics & Animation (2) |
|---|
| , |
Get referred to Brainlab
Find people who can refer or advise you
- Design-related degree or comparable qualification, with approx. 4–5 years of professional experience in motion design
- Proven expertise in developing motion concepts and translating complex technical content into clear visual communication
- Excellent knowledge of After Effects and the Adobe Creative Cloud Suite
- Experience with Premiere or DaVinci, basic audio knowledge
- Skillset in Cinema 4D is a plus (focus on motion graphics)
- Experience in AI-supported concepting and production (e.g. Midjourney or comparable tools, AI video tools such as Veo or similar, prompt-based workflows)
- Solid understanding of photography and video production
- Strong sense of timing, composition and brand experience
- Confident communication skills and experience presenting work to stakeholders
- Ability to work in a fast-paced, collaborative and deadline-oriented environment
- Highly self-motivated with critical attention to detail and quality
- Team-oriented, reliable and solution-driven personality
- Open to learning new things, as well as sharing knowledge
- Interested in medical procedures and healthcare
- Professional proficiency in English, German is a plus
- Development of motion design concepts for product communication, campaigns and internal initiatives
- Creation of high-quality motion graphics
- Development of storyboards, style frames and visual concepts
- Translation of our communication design language into motion
- Integration of AI-supported workflows into concepting and production (e.g. AI video, generative tools)
- Independent project responsibility from briefing to delivery
- Presentation of concepts and results to internal stakeholders and the Creative Director
- Collaboration in photo shootings and video productions
- Independent management and execution of smaller day-to-day operational tasks
Brainlab is a medical technology company that creates software and hardware to improve surgeries, radiosurgery treatments, and operating room efficiency. It serves hospitals and clinics by providing digital tools that enhance surgical precision and patient outcomes. The core products include image-guided navigation, planning software, and connected hardware that work together to guide procedures. Revenue comes from selling software licenses, hardware devices, and ongoing subscription services that include updates and support. The company differentiates itself by offering integrated digital medical technologies that combine software and hardware for a seamless clinical workflow, backed by service agreements. Its goal is to help healthcare providers perform safer, more accurate procedures and run operating rooms more efficiently through data-driven tools and ongoing support.
Company Size
1,001-5,000
Company Stage
Early VC
Total Funding
$7.3M
Headquarters
Munich, Germany
Founded
1989
Get referred to Brainlab
Find people who can refer or advise you
Simplify's Take
What believers are saying
- Recurring software and support contracts create steadier revenue than device sales alone.
- Hospital customers value tools that improve surgical precision and patient outcomes.
- Minority investments can broaden Brainlab's ecosystem across neurotech and healthcare IT.
What critics are saying
- Capital deployed into rivals like Nexstim and AB S.A. strengthens future competitors.
- Minority investments produce uncertain returns and dilute focus on Brainlab's core platform.
- Hospitals can consolidate workflows around competing software vendors, reducing Brainlab's pricing power.
What makes Brainlab unique
- Brainlab combines surgical software, hardware, and subscription services for hospitals.
- Its core focus is critical surgery, radiosurgery, and operating-room efficiency.
- The company also invests in adjacent medtech and healthcare IT vendors.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Flexible Work Hours
Paid Vacation
Paid Holidays
Conference Attendance Budget
Professional Development Budget
Wellness Program
Mental Health Support
Stock Options
Company Equity
401(k) Retirement Plan
401(k) Company Match
Phone/Internet Stipend
Home Office Stipend
Health Insurance
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 2%Brainlab and Precision NeuroMed have formed a strategic partnership to develop an AI-enabled treatment planning platform for convection enhanced delivery (CED) to the brain. Brainlab has taken an equity stake in the clinical-stage biotechnology company as part of the collaboration. The partnership aims to create a cloud-based CED Treatment Planning System that combines Brainlab's medical imaging expertise with Precision NeuroMed's molecular flow simulation software. The platform will use advanced imaging and AI-driven optimisation to personalise drug distribution, overcoming blood-brain barrier limitations that restrict most systemically administered drugs. Initial development will focus on supporting Precision NeuroMed's lead drug, PNM-201, for recurrent glioblastoma. The companies plan to expand the platform to enable delivery of therapies for epilepsy, Parkinson's disease, Alzheimer's disease and ALS.
Lovell Government Services, a Service-Disabled Veteran-Owned Small Business, has been awarded a Patient Monitoring and Capital Equipment contract with Brainlab, expanding access to advanced surgical technology across VA and DoD facilities. The partnership adds capital equipment and patient monitoring solutions to Lovell's federal portfolio, which previously focused on consumables. Brainlab, a digital medical technology company operating in 4,000 hospitals across 120 countries, first partnered with Lovell in 2024. The company develops integrated hardware and software for surgery and radiation therapy. The contract builds on Lovell's strong 2025 performance, which included over $100 million in sales, expanded Defence Logistics Agency Electronic Catalog access, and pharmaceutical distribution accreditation. Founded in 2013, Lovell has appeared four times on the Inc. 5000 list.
Brainlab has received FDA 510(k) clearance and launched its Spine Mixed Reality Navigation system in the United States.
Medtech firm Brainlab has decided to postpone its planned initial public offering (IPO) in Frankfurt, which was expected to raise $378 million.
Brainlab AG is launching an IPO on the Frankfurt Stock Exchange to raise up to €200 million, aiming to enhance its digital healthcare ecosystem. The company reported record revenues of €239 million and a 22.4% EBITDA margin in the first half of FY 2024/25. The IPO proceeds will support commercialization, expansion into new clinical applications, and balance sheet strengthening. Brainlab targets mid-term revenue growth of 10-13% and an EBITDA margin in the mid-20s, with a long-term goal of up to 30%.